名稱 | KIF5B(E15)-RET(E12) G810R/BaF3 |
型號(hào) | CBP73231 |
報(bào)價(jià) | ![]() |
特點(diǎn) | KIF5B(E15)-RET(E12) [G810R]/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 拯救偏頭痛!CGRP及其受體拮抗劑研究進(jìn)展
- ATCC細(xì)胞株的特殊性質(zhì)或標(biāo)志必須在整個(gè)培養(yǎng)期間始終存在
- 【連載-企業(yè)參考品】 前列腺癌的診斷參考品的選擇
- KIR3DL3/HHLA2細(xì)胞篩選模型
- 重磅!科學(xué)家成功利用免疫細(xì)胞運(yùn)輸抗癌藥物至腫瘤靶點(diǎn)
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- ANG TIE2:重塑千億血管靶向治療市場(chǎng),“血管-免疫”協(xié)同治療革命
- 黃金賽道——CDH17靶點(diǎn)
- 免疫治療的下一個(gè)靶標(biāo):腫瘤相關(guān)巨噬細(xì)胞?
- IHC第三方質(zhì)控品——病理質(zhì)控基石,精準(zhǔn)診斷起點(diǎn)
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73231KIF5B(E15)-RET(E12) G810R/BaF3

- 詳細(xì)內(nèi)容
CBP73231 | |
I. Introduction | |
Cell Line Name: | KIF5B(E15)-RET(E12) [G810R]/BaF3 |
Host Cell: | BA/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+2ug/ml puromycin |
Mycoplasma Status: | Negative |
II.Background | |
KIF5B, kinesin family member 5B, is a microtubule motor protein involved in cargo transportation (PMID: 12743033), including lysosome and mitochondria transportation (PMID: 30058692). KIF5B fusions with RET (PMID: 22327624, PMID: 32094155), MET (PMID: 29284707), and ALK (PMID: 21656749, PMID: 21757253) have been frequently identified in lung cancer (PMID: 22327623), and Kif5b expression has been associated with poor prognosis in oral squamous cell carcinoma (PMID: 30058692). | |
III. Representative Data | |
1. WB of KIF5B-RET (G810R)/BaF3 | |
2.Sanger of KIF5B-RET (G810R)/BaF3 | |
3. Anti-proliferation assay | |
Figure 4. CTG Proliferation Assay of BaF3 KIF5B-Ret (S) G810R (C3). |